Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: R>G> who wrote (1821)	6/25/1998 7:08:00 PM
From: george willse	Read Replies (3) \| Respond to of 5402

Chief, Prospector and RG - Thanks for the welcome and quick replies! One thing I don't understand is that SGNC has a second generation product, and they've tested (at least the first generation product) on humans. RG references European countries in his time line (Italy, Belgiium). What happened to the Japan testing? And why animal testing if SGNC has already done it on humans? This seems like a step backward. The only things I can think of is that the second generation product is much different than the first and that one country does not accept another's testing/approvals. Thanks, George PS. Chief, I've already emailed your url across the country. Great job on the rubber gloves!! LOL "Does your dog bite???" ...peter sellers